INSM Stock Summary and Trading Ideas (Insmed | NASDAQ:INSM)

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

What symbol and exchange does Insmed shares trade?

Insmed trades on the NASDAQ stock market under the symbol INSM.

What is Insmed stock price doing today?

As of March 6, 2026, INSM stock price declined to $140.85 with 1,443,333 million shares trading.

What is Insmed's Beta?

INSM has a beta of 0.67, meaning it tends to be less sensitive to market movements. INSM has a correlation of 0.05 to the broad based SPY ETF.

How much is Insmed worth?

INSM has a market cap of $30.04 billion. This is considered a Large Cap stock.

How much money does Insmed make?

Last quarter Insmed reported $264 million in Revenue and -$1.54 earnings per share. This fell short of revenue expectation by $-91,602 and missed earnings estimates by -$.41.

What is the highest and lowest price Insmed traded in the last 3 year period?

In the last 3 years, INSM traded as high as $212.75 and as low as $16.04.

What are the top ETFs holding Insmed?

The top ETF exchange traded funds that INSM belongs to (by Net Assets): VTI, QQQ, VB, VO, VXF.

Is Insmed (INSM) a good investment?

INSM has outperformed the market in the last year with a return of +81.6%, while the SPY ETF gained +16.6%. However, in the most recent history, INSM shares have underperformed the stock market with its stock returning -31.0% in the last 3 month period and -12.5% for the last 2 week period, while SPY has returned -1.6% and -1.7%, respectively.

What are the support and resistance levels for Insmed (INSM)?

INSM support price is $139.85 and resistance is $147.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSM shares will trade within this expected range on the day.